{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T14:14:35Z","timestamp":1720275275268},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jcv.2016.08.294","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T07:44:49Z","timestamp":1471247089000},"page":"43-47","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Economic impact of switching rubella IgG methodologies to the prenatal public health program in Alberta"],"prefix":"10.1016","volume":"83","author":[{"given":"Florence Y.","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas C.","family":"Dover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen L.","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2016.08.294_bib0005","first-page":"1091","article-title":"Evaluation of rubella screening in pregnant women","volume":"159","author":"Gyorkos","year":"1998","journal-title":"CMAJ"},{"key":"10.1016\/j.jcv.2016.08.294_bib0010","series-title":"Obstetrics: Normal and Problem Pregnancies","author":"Gabbe","year":"2002"},{"key":"10.1016\/j.jcv.2016.08.294_bib0015","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1503\/cmaj.050230","article-title":"Congenital rubella syndrome despite maternal antibodies","volume":"172","author":"Banerji","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.jcv.2016.08.294_bib0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1128\/CDLI.8.3.552-555.2001","article-title":"Comparison of immulite with vidas for detection of infection in a low-prevalence population of pregnant women in The Netherlands","volume":"8","author":"Vlaspolder","year":"2001","journal-title":"Clin. Diagn. Lab Immunol."},{"key":"10.1016\/j.jcv.2016.08.294_bib0025","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/CDLI.8.4.785-787.2001","article-title":"Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems","volume":"8","author":"Diepersloot","year":"2001","journal-title":"Clin. Diagn. Lab Immunol."},{"key":"10.1016\/j.jcv.2016.08.294_bib0030","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1128\/CVI.05207-11","article-title":"Evaluation of the Bio-Rad BioPlex Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG multiplex bead immunoassay","volume":"18","author":"Binnicker","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jcv.2016.08.294_bib0035","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/CVI.00688-12","article-title":"Performance of the Elecsys Rubella IgG assay in the diagnostic laboratory setting for assessment of immune status","volume":"20","author":"Enders","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jcv.2016.08.294_bib0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/CVI.00603-12","article-title":"Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays","volume":"20","author":"Dimech","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jcv.2016.08.294_bib0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2015.11.022","article-title":"Performance of 14 rubella IgG immunoassays on samples with low positive or negative haemagglutination inhibition results","volume":"74","author":"Huzly","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2016.08.294_bib0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/CMR.00045-15","article-title":"Standardization of assays that detect anti-rubella virus IgG antibodies","volume":"29","author":"Dimech","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jcv.2016.08.294_bib0055","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.vaccine.2014.12.022","article-title":"Determining rubella immunity in pregnant Alberta women 2009\u20132012","volume":"33","author":"Lai","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2016.08.294_bib0060","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/S0264-410X(00)00139-0","article-title":"Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland","volume":"18","author":"Davidkin","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2016.08.294_bib0065","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.08.294_bib0070","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1016\/j.vaccine.2012.09.075","article-title":"Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel","volume":"30","author":"Levine","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2016.08.294_bib0075","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2105\/AJPH.93.8.1274","article-title":"The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia","volume":"93","author":"Francis","year":"2003","journal-title":"Am. J. Public Health"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216304978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216304978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T23:50:31Z","timestamp":1657065031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653216304978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":15,"alternative-id":["S1386653216304978"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2016.08.294","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic impact of switching rubella IgG methodologies to the prenatal public health program in Alberta","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2016.08.294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}